Can newborn screening be cost benefit procedure if preventing serious complications of cystic fibrosis?
<p>Cystic Fibrosis (CF) is a common inherited disease with reported mean prevalence of 0.737/10,000 in 27 EU countries (Farrell J Cyst Fibros. 2008). Still, many EU countries have not implemented CF in the Newborn Screening (NBS) programme, including our country. We report the case of a 7-mon...
Saved in:
Main Authors: | Mirna Šubat-Dežulović (Author), Gordana Pelčić (Author), Ana Valković (Author), Sanja Flajšman-Raspor (Author), Goran Pelčić (Author), Anamarija Gjuran Coha (Author) |
---|---|
Format: | Book |
Published: |
Archives of Nursing Practice and Care - Peertechz Publications,
2021-12-03.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Newborn Screening for Cystic Fibrosis
Published: (2020) -
The History of Cystic Fibrosis
by: Javier Pérez-Frías, et al.
Published: (2019) -
Cystic Fibrosis Facts, Management and Advances
Published: (2021) -
Cystic Fibrosis Heterogeneity and Personalized Treatment
Published: (2020) -
Cystic Fibrosis Renewed Hopes Through Research
Published: (2012)